Clinical Trial Update: A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety, reactogenicity, and immunogenicity of the IN001 mRNA vaccine for herpes zoster in healthy participants; currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• IN001 mRNA Vaccine (IN001 mRNA vaccine)

Snippet

Sponsor: Shenzhen Shenxin Biotechnology Co., Ltd | Conditions: Herpes Zoster | Phase 2 | Status: NOT_YET_RECRUITING